Helen Te to Antiviral Agents
This is a "connection" page, showing publications Helen Te has written about Antiviral Agents.
Connection Strength
1.985
-
Hepatitis B transmission/reactivation associated with Hepatitis B core antibody and Hepatitis C nucleic acid testing positive organs: A report from the Organ Procurement and Transplantation Network Disease Transmission Advisory Committee. Transpl Infect Dis. 2024 Nov; 26 Suppl 1:e14305.
Score: 0.658
-
Viral hepatitis: Guidelines by the American Society of Transplantation Infectious Disease Community of Practice. Clin Transplant. 2019 09; 33(9):e13514.
Score: 0.460
-
Peginterferon alpha-2a combination therapies in chronic hepatitis C patients who relapsed after or had a viral breakthrough on therapy with standard interferon alpha-2b plus ribavirin: a pilot study of efficacy and safety. Dig Dis Sci. 2005 Apr; 50(4):719-26.
Score: 0.174
-
Biopsy Specimens From Allograft Liver Contain Histologic Features of Hepatitis C Virus Infection After Virus Eradication. Clin Gastroenterol Hepatol. 2017 Aug; 15(8):1279-1285.
Score: 0.101
-
Sofosbuvir plus ledispasvir for recurrent hepatitis C in liver transplant recipients. Liver Transpl. 2016 11; 22(11):1536-1543.
Score: 0.097
-
Lower Observed Hepatocellular Carcinoma Incidence in Chronic Hepatitis B Patients Treated With Entecavir: Results of the ENUMERATE Study. Am J Gastroenterol. 2016 09; 111(9):1297-304.
Score: 0.095
-
Entecavir safety and effectiveness in a national cohort of treatment-naïve chronic hepatitis B patients in the US - the ENUMERATE study. Aliment Pharmacol Ther. 2016 Jan; 43(1):134-44.
Score: 0.090
-
An interferon-free antiviral regimen for HCV after liver transplantation. N Engl J Med. 2014 Dec 18; 371(25):2375-82.
Score: 0.085
-
Hepatitis E virus infection in a liver transplant recipient in the United States: a case report. Transplant Proc. 2013 Mar; 45(2):810-3.
Score: 0.075
-
Durability of sustained response shown in paediatric patients with chronic hepatitis C who were treated with interferon alfa-2b plus ribavirin. J Viral Hepat. 2012 Apr; 19(4):263-70.
Score: 0.069
-
Evaluation of early null response to pegylated interferon and ribavirin as a predictor of therapeutic nonresponse in patients undergoing treatment for chronic hepatitis C. Am J Gastroenterol. 2011 Mar; 106(3):452-8.
Score: 0.064
-
Varicella infection following varicella vaccination in a liver transplant recipient. Am J Transplant. 2002 Oct; 2(9):880-2.
Score: 0.009
-
Results of steroid-based therapy for the hepatitis C-autoimmune hepatitis overlap syndrome. Am J Gastroenterol. 2001 Oct; 96(10):2984-91.
Score: 0.009